Allergy Drops and Mouth Itching: The Most Common Reaction

Yes. Mouth itching is the most commonly reported side effect of sublingual immunotherapy, affecting a large share of patients in clinical reviews. It happens because the allergen extract sits against immune cells under the tongue, triggering a brief local histamine response. For most people the itch is mild, begins within the first couple of weeks, and gradually becomes less noticeable as the body builds tolerance to the daily dose. An itch that stays confined to the mouth and fades on its own is considered expected. You should still tell your allergist about any reaction so they can confirm it is local and not part of a broader response.

Each episode of oral itching usually lasts from a few minutes up to about an hour after a dose. Over the course of treatment, the itching tends to be most noticeable during the first one to two weeks and then eases as tolerance develops, often becoming minimal within the first month or two. Everyone is different, so some people notice it longer than others. If itching is still strong or worsening after a few weeks, that is worth a conversation with your provider, who may adjust the dose or suggest taking an antihistamine beforehand to make the build-up phase more comfortable.

Several simple steps can help. Holding the dose steadily under the tongue as directed, avoiding eating or drinking for a short period afterward, and taking the dose at a consistent time can all reduce irritation. Some allergists recommend a non-drowsy antihistamine before dosing during the early weeks to blunt the histamine-driven itch. Cool water afterward can also soothe the sensation. Do not change your dose on your own; if the itching is hard to tolerate, ask your provider, who can tailor the schedule. The goal is to stay comfortable while your immune system adapts, which usually makes the itch fade on its own.

Not exactly. Oral itching shows that the allergen is reaching the immune cells under your tongue, which is how the treatment is designed to work, but the itch itself is not a reliable measure of long-term benefit. Many people who respond well have only mild early itching, and the absence of itching does not mean the drops are failing. Real benefit, such as reduced allergy symptoms, develops gradually over months and is best assessed by your allergist. Think of the itch as a sign of contact at the right spot, not as a progress meter for your results.

Be cautious if itching is joined by rapid swelling of the lips or tongue, tightness in the throat, difficulty breathing or swallowing, hives spreading beyond the mouth, or lightheadedness. These point to a more serious reaction, which is uncommon with sublingual immunotherapy but possible, and they need prompt medical attention; call emergency services for breathing trouble or throat tightness. Itching that is severe, lasts for hours, or keeps getting worse week over week also deserves a call to your allergist even without those warning signs, so they can reassess your dose and confirm the reaction is staying local.

Mouth itching tops the list because of where the dose is placed. Allergy drops are designed to be held under the tongue, directly against mucosa packed with immune cells, and that same contact that makes the treatment work is what triggers a local histamine release and an itchy feeling. In pooled safety data, local oral reactions affected roughly 40.8% of patients, far outnumbering systemic effects, which occur in fewer than 0.1% of patients in our program, and itching is the most frequently described of those local reactions. In other words, the high frequency is a direct consequence of the delivery route, not a sign that anything is going wrong. It is an expected part of how the under-the-tongue method works.